Abstract Objectives Carbapenem-resistant Gram-negative bacteria (CRGNB) pose a clinical
challenge. We attempted to estimate the mortality burden of CRGNB among haematological …

Background Carbapenem-resistant Gram-negative bacteria (CRGNB) bloodstream infection
(BSI) pose a significant threat to the prognosis of hematologic malignancies (HM) patients …

Objectives To determine the prevalence, risk factors, treatments, and outcomes of
bloodstream infections (BSIs) due to carbapenem-resistant Enterobacteriaceae (CRE) in …

In developed countries, hematological malignancies (HM) account for 8 to 10% of cancers
diagnosed annually and one-third of patients with HM (HMP) are expected to die from their …

BACKGROUND: The aim of this study is to assess the factors influencing the early mortality
(7-day after index blood culture) in haematological malignancy patients with Gram negative …

Background Carbapenem-resistant gram-negative bacteria (CRGNB) continue to present a
global healthcare crisis. We aimed to identify emerging trends of CRGNB over nearly 2 …

Background/purpose A substantial number of carbapenem-resistant Gram-negative bacilli
(CR GNB) have been identified among the etiologic multidrug-resistant GNB in healthcare …

Background Enterobacteriaceae (EB) and non-fermentative bacteria (NFB) are the main
pathogens responsible for gram-negative bloodstream infections (GN-BSI) in patients with …

Background This study aimed to identify risk factors for mortality and outcomes in
hematological malignancy (HM) patients with bloodstream infection (BSI) caused by …

The aim of this study was to see if multiresistant Gram-negative bacteremias (MRGNB) are
associated with specific risk factors and/or higher mortality in comparison to sensitive GNB …